Accession Number:

AD1097328

Title:

Department of Defense Armed Forces Health Surveillance Branch Integrated Biosurveillance Section Northeastern DRC Ebola Surveillance Summary

Descriptive Note:

Technical Report

Corporate Author:

Defense Health Agency Falls Church United States

Personal Author(s):

Report Date:

2019-01-25

Pagination or Media Count:

4.0

Abstract:

From 30 APR 2018 to 22 JAN 2019, the Democratic Republic of the Congo DRC Ministry of Health MOH has reported 713 50 confirmed and probable Ebola virus disease EVD cases, from 18 1, Kayna health zones HZs in North Kivu and Itu provinces in northeastern DRC with an additional 203 suspected cases are under investigation. While EVD cases initially peaked in early AUG 2018, a second and third peak occurred in mid-and late-NOV 2018, with an increase in incidence throughout NOV compared to previous months see WHOs epidemic curve. Katwa HZ continues to account for the majority of newly confirmed and probable cases from 15-22 JAN 2019, this HZ has reported 60 of all newly confirmed and probable cases. According to the MOH, families from confirmed EVD cases in Katwa HZ are reluctant to be vaccinated this may explain why the HZ continues to report the majority of new cases. Among the confirmed and probable cases, there have been 439 32 deaths case fatality proportion 62. As of 22 JAN 2019, confirmed and probable cases have been reported from Beni226 1, Katwa146 30, Mabalako 106 1, Kalunguta53 1, Butembo 52 2, Oicha27 2, Kyondo12 1, Vuhovi11 2, Masereka 8, Musienene71, Kayna5, Biena42, Manguredjipa3 2 and Mutwanga3 HZsin North Kivu Province. In Ituri Province, cases have been reported from Komanda27, Mandima20, Tchomia2, and Nyankunde1 HZs. From 1 DEC 2018 to 14 JAN 2019, 36 of newly confirmed cases have occurred in children 15 years of age, according to WHO. As of 23 JAN 2019, no confirmed EVD cases have been reported outside of the DRC however, the high level of population movement between the affected areas and neighboring countries continues to create opportunities for cross-border disease transmission. As of 28 SEP 2018, WHO assessed the risk of EVD spread at the national and regional levels as very high and the global risk as low.

Subject Categories:

  • Medicine and Medical Research
  • Microbiology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE